[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ECSP066700A - SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES - Google Patents

SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES

Info

Publication number
ECSP066700A
ECSP066700A EC2006006700A ECSP066700A ECSP066700A EC SP066700 A ECSP066700 A EC SP066700A EC 2006006700 A EC2006006700 A EC 2006006700A EC SP066700 A ECSP066700 A EC SP066700A EC SP066700 A ECSP066700 A EC SP066700A
Authority
EC
Ecuador
Prior art keywords
diseases
treatment
sulfonamide derivatives
disorders
preparation
Prior art date
Application number
EC2006006700A
Other languages
Spanish (es)
Inventor
Mark Edward Bunnage
David Anthony Price
Alan Daniel Brown
Paul Alan Glossop
Charlotte Alice Louise Lane
Russell Andrew Lewthwaite
Kim James
Ian Brian Moses
Nicholas Murray Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP066700(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP066700A publication Critical patent/ECSP066700A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a compuestos de fórmula (1) (consta gráfico) y a procedimientos para la preparación de, a intermedios usados en la preparación de, a composiciones que contienen y a los usos de tales derivados. Los compuestos de acuerdo con la presente invención son útiles en numerosas enfermedades, trastornos y afecciones, en particular enfermedades, trastornos y afecciones inflamatorias, alérgicas y respiratoriasThe invention relates to compounds of formula (1) (graphical) and methods for the preparation of, intermediates used in the preparation of, compositions containing and the uses of such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

EC2006006700A 2004-01-22 2006-07-13 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES ECSP066700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09

Publications (1)

Publication Number Publication Date
ECSP066700A true ECSP066700A (en) 2006-10-31

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006700A ECSP066700A (en) 2004-01-22 2006-07-13 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES

Country Status (7)

Country Link
CR (1) CR9838A (en)
CY (1) CY1107107T1 (en)
EC (1) ECSP066700A (en)
HK (1) HK1096379A1 (en)
HR (1) HRP20070542T3 (en)
IL (1) IL176564A (en)
MA (1) MA28302A1 (en)

Also Published As

Publication number Publication date
CR9838A (en) 2008-04-21
IL176564A (en) 2011-11-30
HK1096379A1 (en) 2007-06-01
IL176564A0 (en) 2006-10-31
HRP20070542T3 (en) 2008-02-29
CY1107107T1 (en) 2012-10-24
MA28302A1 (en) 2006-11-01

Similar Documents

Publication Publication Date Title
ECSP066701A (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
CR8649A (en) FORMAMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
UY28721A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
CR10700A (en) SULFONAMIDE DERIVATIVES
PA8604301A1 (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
ECSP088717A (en) AMINA DERIVATIVES
UY28343A1 (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
ECSP11010754A (en) USEFUL TRIAZOL DERIVATIVES FOR THE TREATMENT OF DISEASES
CR8636A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
ECSP056164A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
PA8627001A1 (en) COMPOUNDS FOR THE TREATMENT OF DISEASES
ECSP066700A (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
ECSP066832A (en) COMPOUNDS FOR THE TREATMENT OF DISEASES
UY28819A1 (en) FORMAMIDA DERIVATIVES FOR THE TREATMENT OF DISEASES
CR8514A (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
CR8513A (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
UY28810A1 (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
CU23537B7 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
CU23532B7 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
DOP2005000037A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
DOP2004000902A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
DOP2004000921A (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
DOP2005000043A (en) COMPOUNDS FOR THE TREATMENT OF DISEASES
GT200500056A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
CU20060180A7 (en) FORMAMIDA DERIVATIVES FOR THE TREATMENT OF DISEASES